STOCK-BASED COMPENSATION	3 Months Ended
Nov. 30, 2025
Retirement Benefits [Abstract]
STOCK-BASED COMPENSATION	NOTE 8 – STOCK-BASED COMPENSATION *Restricted Stock Awards (“RSAs”)* All RSAs were vested as of August 31, 2025 and the Company did not issue any additional RSAs for the three months ended November 30, 2025. A summary of RSA for the three months ended November 30, 2025 is presented below: During the three months ended November 30, 2025 and 2024, the Company recognized compensation expenses of $0 and $471 for RSAs, respectively. *Restricted Stock Units (“RSUs”)* Awards of Restricted Stock Units (“RSUs”) are generally subject to forfeiture if employment terminates prior to vesting. The Company’s RSU’s consist of time-based units, that are settled in shares of the Company’s common stock upon vesting. On September 1, 2025, the Company executed employment agreements with select executives, committing to issue RSUs with a total annual fair value of $1,694 for the duration of their anticipated employment term. The quantity of RSUs granted each year will be determined on September 1, based on the prevailing price of the Company’s common stock on that date. These RSUs will vest in four equal installments over one year following September 1. The estimated employment term for these executives is two years. The RSUs are classified as equity awards, as settlement occurs in shares and the number of shares delivered upon vesting is set. The aggregate grant date fair value of the RSUs issued is $2,263, and this amount will be recognized on a straight-line basis over the two-year period. On September 1, 2025, the Company granted an initial tranche of 38,830 Restricted Stock Units (RSUs), determined using a stock price of $43.62 as of that date. These RSUs are scheduled to vest over the course of one year commencing on September 1, 2025. During the three months ended November 30, 2025, 25,791 RSUs were forfeited and 3,260 RSUs were vested. As of November 30, 2025, 9,779 RSUs remain unvested. Share-based compensation expense is recorded in “General and administrative expenses” in the Condensed Consolidated Statements of Operations. During the three months ended November 30, 2025, the Company recognized compensation expenses of $142 for RSUs. As of November 30, 2025, unrecognized compensation expense for the RSUs is $995. There were no RSUs outstanding as of August 31, 2025. *Equity Classified Warrants* In June 2025, the Company issued three warrant offerings (Placement Agent Warrants, Strategic Advisor Warrants, and Representative Warrants). Each warrant offering was designated as equity classified share-based compensation in accordance with ASC 718. For further information regarding the initial measurement of these warrants, refer to Note 10 of the Company’s Annual Report on Form 10-K for the year ended August 31, 2025. During the three months ended November 30, 2025, 63,460 warrants were exercised at a price of $5.40 per share. As of November 30, 2025 and August 31, 2025, 3,043,654 and 3,107,114 of the warrants were outstanding, respectively. No share based compensation expense was recorded for these warrants during the three months ended November 30, 2025 and November 30, 2024.

STOCK-BASED COMPENSATION

3 Months Ended

Nov. 30, 2025

NOTE 8 – STOCK-BASED COMPENSATION

Restricted Stock Awards (“RSAs”)

All RSAs were vested as of August 31, 2025 and the Company did not issue any additional RSAs for the three months ended November 30, 2025.

A summary of RSA for the three months ended November 30, 2025 is presented below:

During the three months ended November 30, 2025 and 2024, the Company recognized compensation expenses of $0 and $471 for RSAs, respectively.

Restricted Stock Units (“RSUs”)

Awards of Restricted Stock Units (“RSUs”) are generally subject to forfeiture if employment terminates prior to vesting. The Company’s RSU’s consist of time-based units, that are settled in shares of the Company’s common stock upon vesting.

On September 1, 2025, the Company executed employment agreements with select executives, committing to issue RSUs with a total annual fair value of $1,694 for the duration of their anticipated employment term. The quantity of RSUs granted each year will be determined on September 1, based on the prevailing price of the Company’s common stock on that date. These RSUs will vest in four equal installments over one year following September 1. The estimated employment term for these executives is two years. The RSUs are classified as equity awards, as settlement occurs in shares and the number of shares delivered upon vesting is set. The aggregate grant date fair value of the RSUs issued is $2,263, and this amount will be recognized on a straight-line basis over the two-year period.

On September 1, 2025, the Company granted an initial tranche of 38,830 Restricted Stock Units (RSUs), determined using a stock price of $43.62 as of that date. These RSUs are scheduled to vest over the course of one year commencing on September 1, 2025. During the three months ended November 30, 2025, 25,791 RSUs were forfeited and 3,260 RSUs were vested. As of November 30, 2025, 9,779 RSUs remain unvested. Share-based compensation expense is recorded in “General and administrative expenses” in the Condensed Consolidated Statements of Operations. During the three months ended November 30, 2025, the Company recognized compensation expenses of $142 for RSUs. As of November 30, 2025, unrecognized compensation expense for the RSUs is $995. There were no RSUs outstanding as of August 31, 2025.

Equity Classified Warrants

In June 2025, the Company issued three warrant offerings (Placement Agent Warrants, Strategic Advisor Warrants, and Representative Warrants). Each warrant offering was designated as equity classified share-based compensation in accordance with ASC 718. For further information regarding the initial measurement of these warrants, refer to Note 10 of the Company’s Annual Report on Form 10-K for the year ended August 31, 2025.

During the three months ended November 30, 2025, 63,460 warrants were exercised at a price of $5.40 per share. As of November 30, 2025 and August 31, 2025, 3,043,654 and 3,107,114 of the warrants were outstanding, respectively. No share based compensation expense was recorded for these warrants during the three months ended November 30, 2025 and November 30, 2024.